[1]
Omar Sajjad et al. 2023. META-ANALYSIS OF THE PREVALENCE OF RENAL IMPAIRMENT IN PATIENTS WITH TESTICULAR CANCER RECEIVING *CISPLATIN-BASED CHEMOTHERAPY. Journal of Population Therapeutics and Clinical Pharmacology. 30, 19 (Dec. 2023), 2457–2461. DOI:https://doi.org/10.53555/81m14g32.